Semaglutide Research Compound (SM)

"Premium grade Semaglutide validation."

Semaglutide is a long-acting analog of glucagon-like peptide-1 (GLP-1) with 94% sequence homology to native GLP-1, engineered with an albumin-binding fatty-acid side chain for extended plasma half-life. It is a potent GLP-1 receptor agonist studied in GLP-1 pathway and metabolic research; the STEP 1 phase 3 trial documented its effects on body weight in adults with obesity (Wilding et al., N Engl J Med 2021, PMID 33567185). Semaglutide research peptide is supplied lyophilized at ≥99% purity verified by HPLC, with identity confirmed by mass spectrometry and a batch-specific Certificate of Analysis (COA) included. Store lyophilized powder at −20 °C, protected from light and moisture. For laboratory research use only — not for human or animal consumption.